Literature DB >> 6779329

Intravenous self-administration of cocaine and norcocaine by dogs.

M E Risner, B E Jones.   

Abstract

The potency of cocaine, relative to d-amphetamine, to initiate and maintain intravenous self-administration behavior by dogs (n = 5) was determined. Response-contingent infusions of cocaine (at unit doses of 0.15, 0.30 and 0.60 mg/kg/infusion) and d-amphetamine (at unit doses of 0.05 and 0.10 mg/kg/infusion) were available during daily 4-h sessions on a FR1 reinforcement schedule. By comparing the dose-response curves of the two drugs, it was found that 1 mg of amphetamine is equivalent to 5.3 mg of cocaine (95% confidence limits = 3.8--9.1 mg). In a second experiment, pretreatment with the alpha-adrenergic antagonist phenoxybenzamine (in doses ranging from 0.125--2.0 mg/kg, IV) did not produce any appreciable changes in responding for cocaine (0.2 mg/kg/infusion) by dogs (n = 9). In contrast, when the same animals were pretreated with the dopaminergic antagonist pimozide (in doses ranging from 5--40 mg/kg, IV), subsequent responding for cocaine was increased in a dose-dependent manner. In a third experiment it was determined that norcocaine, the N-demethylated metabolite of cocaine, would maintain self-administration behavior by dogs (n = 4) when it was substituted for cocaine. As expected, when saline was substituted for cocaine, responding was not maintained.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6779329     DOI: 10.1007/bf00433258

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Studies on sympathomimetic amines. II. The biotransformation and physiological disposition of d-amphetamine, d-p-hydroxyamphetamine and d-methamphetamine.

Authors:  J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1954-03       Impact factor: 4.030

2.  Self-administration of CNS stimulants by dog.

Authors:  M E Risner; B E Jones
Journal:  Psychopharmacologia       Date:  1975-09-17

3.  Characteristics of unlimited access to self-administered stimulant infusions in dogs.

Authors:  M E Risner; B E Jones
Journal:  Biol Psychiatry       Date:  1976-10       Impact factor: 13.382

4.  Psychomotor stimulant self administration as a function of dosage per injection in the rhesus monkey.

Authors:  M C Wilson; M Hitomi; C R Schuster
Journal:  Psychopharmacologia       Date:  1971

5.  Aminergic influences on intravenous cocaine self-administration by Rhesus monkeys.

Authors:  M C Wilson; C R Schuster
Journal:  Pharmacol Biochem Behav       Date:  1974 Sep-Oct       Impact factor: 3.533

6.  Cocaine-reinforced behavior in rats: effects of reinforcement magnitude and fixed-ratio size.

Authors:  R Pickens; T Thompson
Journal:  J Pharmacol Exp Ther       Date:  1968-05       Impact factor: 4.030

7.  Norcocaine: a pharmacologically active metabolite of cocaine found in brain.

Authors:  R L Hawks; I J Kopin; R W Colburn; N B Thoa
Journal:  Life Sci       Date:  1974-12-15       Impact factor: 5.037

8.  Role of noradrenergic and dopaminergic processes in amphetamine self-administration.

Authors:  M Risner; B E Jones
Journal:  Pharmacol Biochem Behav       Date:  1976-10       Impact factor: 3.533

9.  Brief communication. Comparative pharmacology of norcocaine in M. mulatta and M. fascicularis.

Authors:  M C Wilson; J A Bedford; A H Kibbe; J A Sam
Journal:  Pharmacol Biochem Behav       Date:  1978-07       Impact factor: 3.533

10.  Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.

Authors:  J R WEEKS
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

View more
  20 in total

1.  Differentiating the rapid actions of cocaine.

Authors:  Roy A Wise; Eugene A Kiyatkin
Journal:  Nat Rev Neurosci       Date:  2011-06-02       Impact factor: 34.870

2.  Habit-forming actions of nomifensine in nucleus accumbens.

Authors:  W A Carlezon; D P Devine; R A Wise
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

3.  Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors.

Authors:  D W Self; J D Belluzzi; S Kossuth; L Stein
Journal:  Psychopharmacology (Berl)       Date:  1996-02       Impact factor: 4.530

4.  Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats.

Authors:  R A Wise; A Murray; M A Bozarth
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration.

Authors:  L L Peoples; M O West
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

6.  Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats.

Authors:  R A Wise; P Newton; K Leeb; B Burnette; D Pocock; J B Justice
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

7.  Bilateral intra-accumbens self-administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride.

Authors:  G D Phillips; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

Review 8.  Dopamine and reward: the anhedonia hypothesis 30 years on.

Authors:  Roy A Wise
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

9.  Conditioned contribution of peripheral cocaine actions to cocaine reward and cocaine-seeking.

Authors:  Bin Wang; Zhi-Bing You; Erik B Oleson; Joseph F Cheer; Stephanie Myal; Roy A Wise
Journal:  Neuropsychopharmacology       Date:  2013-03-27       Impact factor: 7.853

10.  Bidirectional microdialysis in vivo shows differential dopaminergic potency of cocaine, procaine and lidocaine in the nucleus accumbens using capillary electrophoresis for calibration of drug outward diffusion.

Authors:  L Hernandez; N A Guzman; B G Hoebel
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.